Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.
Take two mins to learn more
23 May 2025
For decades, some of the most promising scientific breakthroughs have remained confined to the laboratory—brilliant ideas with transformational potential, but without a clear path to market. Today, that’s changing. A new era is emerging at the intersection of deep science and scalable manufacturing: Deep MakeTech.
From novel materials that reduce emissions to bio-manufacturing methods that revolutionise medicine and food, these innovations are no longer distant visions. They are becoming viable businesses—backed by infrastructure, expertise, and forward-thinking capital. And at the forefront of this movement is EverQuest Capital.
What Is Deep MakeTech?
At its core, Deep MakeTech refers to the fusion of deep technology—breakthroughs rooted in scientific research—and the means to make those breakthroughs real through advanced manufacturing. It’s where disciplines like synthetic biology, materials science, and chemical engineering meet the practical know-how of production, scaling, and supply chain optimization.
But Deep MakeTech isn’t just about clever engineering. It’s about applying science to solve urgent real-world problems—cleaner energy, less waste, more efficient healthcare—and building the companies that can deliver these solutions at scale.
From Discovery to Deployment: The Missing Link
One of the biggest barriers to progress in Deep MakeTech has always been infrastructure. Scientific discoveries need more than funding—they require specialised labs, pilot-scale production facilities, and expert support to transition from prototype to product.
This is where EverQuest Capital’s strategic model stands apart. Through a unique partnership with the UK’s Centre for Process Innovation (CPI), EverQuest provides its portfolio companies with access to world-class testing environments, technical talent, and commercialisation pathways. Startups working on next-generation proteins, circular manufacturing methods, or printed electronics don’t just get capital—they get a launchpad.
Where Capital Meets Capability
EverQuest’s approach isn’t theoretical—it’s visible across a growing portfolio of high-impact ventures:
Descycle is redefining e-waste recycling using proprietary solvents to recover precious metals with minimal environmental impact.
Q5D is automating complex electronics manufacturing for the aerospace and automotive sectors.
MarraBio is engineering bioactive proteins for cultivated meat and life sciences—moving the biotech frontier from lab bench to industrial fermenter.
Each of these companies exemplifies what happens when scientific ingenuity is matched with the tools to scale: faster market readiness, lower technical risk, and greater societal value.
Why Now? Why It Matters.
We are entering a new industrial era—one defined not by volume or velocity, but by value creation through innovation. Governments, corporates, and consumers are demanding technologies that don’t just work, but work better for the planet and people. Investors are taking note, and the global appetite for deep tech is growing.
But meaningful returns don’t come from passive investing. They come from knowing how to spot the right technologies, support the right teams, and surround them with the infrastructure they need to succeed.
That’s the EverQuest model: find the frontier technologies that can reshape entire sectors, and then equip them with everything needed to move from lab to launch.
Investing in the UK’s Industrial Strategy
Deep MakeTech is more than a trend—it’s a necessary evolution. The challenges of the 21st century demand industrial solutions grounded in scientific rigor and delivered at scale. EverQuest Capital is not just investing in this future—it’s building it.
For those ready to back the next wave of industrial innovation, the opportunity is not only timely—it’s tangible.